REGISTERED NUMBER: 10040765 (England and Wales)

Financial Statements for the Year Ended 31 March 2025

for

Fluid Pharma Ltd

Page

Company Information

1

Balance Sheet

2

DIRECTORS:

Dr F Liu

Dr P N Gooden

REGISTERED OFFICE:

Maclaurin Building

Bishop Square

Hatfield

AL10 9NE

REGISTERED NUMBER:

10040765 (England and Wales)

ACCOUNTANTS:

Atraxa Consulting Limited

Brooke's Mill

Armitage Bridge

Huddersfield

West Yorkshire

HD4 7NR

CALLED UP SHARE CAPITAL NOT PAID

21

21

FIXED ASSETS

158,902

189,787

CURRENT ASSETS

60,890

247,101

CREDITORS

Amounts falling due within one year

(173,666

)

(377,013

)

NET CURRENT LIABILITIES

(112,776

)

(129,912

)

TOTAL ASSETS LESS CURRENT LIABILITIES

46,147

59,896

CAPITAL AND RESERVES

46,147

59,896

NOTE TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2024 - 3 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 27 October 2025 and were signed on its behalf by:

Dr P N Gooden - Director